Abstract
For chemical genetics and chemical biology, an important task is the identification of small molecules that are selective against individual targets and can be used as molecular probes for specific biological functions. To aid in the development of computational methods for selectivity analysis, molecular benchmark systems have been developed that capture compound selectivity data for pairs of targets. These molecular test systems are utilized for “selectivity searching” and the analysis of structure–selectivity relationships. Going beyond binary selectivity sets focusing on target pairs, a methodological framework, Molecular Formal Concept Analysis (MolFCA), is described for the definition and systematic mining of compound selectivity profiles.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jacoby, E. (2006) Chemogenomics: drug discovery’s panacea? Mol. Biosyst. 2, 218–220.
Spring, D. R. (2005) Chemical genetics to chemical genomics: small molecules offer big insights. Chem. Soc. Rev. 34, 472–482.
Bajorath, J. (2008) Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery. Expert. Opin. Drug Discov. 3, 1371–1376.
Tan, D. S. (2005) Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat. Chem. Biol 1, 74–84.
Stockwell, B. R. (2004) Exploring biology with small organic molecules. Nature 432, 846–854.
Bredel, M., and Jacoby, E. (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 5, 262–275.
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., and Hopkins, A. L. (2006) Global mapping of pharmacological space. Nat. Biotechnol. 24, 805–815.
Yildirim, M. A., Goh, K., Cusick, M. E., Barabási, A., and Vidal, M. (2007) Drug-target network. Nat. Biotechnol. 25, 1119–1126.
Cheng, Y., and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108.
Stumpfe, D., Ahmed, H. E. A., Vogt, I., and Bajorath, J. (2007) Methods for computer-aided chemical biology. Part 1: design of a benchmark system for the evaluation of compound selectivity. Chem. Biol. Drug Des. 70, 182–194.
Stumpfe, D., Geppert, H., and Bajorath, J. (2008) Methods for computer-aided chemical biology. Part 3: analysis of structure-selectivity relationships through single- or dual-step selectivity searching and Bayesian classification. Chem. Biol. Drug Des. 71, 518–528.
Johnson, M. A., and Maggiora, G. M. (1990) Concepts and applications of molecular similarity. Wiley, New York.
Kubinyi, H. (1998) Similarity and dissimilarity – a medicinal chemist’s view. Perspect. Drug Discov. Des. 11, 225–252.
Peltason, L., and Bajorath, J. (2007) Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes. Chem. Biol. 14, 489–497.
Vogt, I., Stumpfe, D., Ahmed, H. E. A., and Bajorath, J. (2007) Methods for computer-aided chemical biology. Part 2: evaluation of compound selectivity using 2D molecular fingerprints. Chem. Biol. Drug Des. 70, 195–205.
Wassermann, A. M., Geppert, H., and Bajorath, J. (2009) Searching for target-selective compounds using different combinations of multiclass support vector machine ranking methods, kernel functions, and fingerprint descriptors. J. Chem. Inf. Model. 49, 582–592.
Vogt, I., Ahmed, H. E. A., Auer, J., and Bajorath, J. (2008) Exploring structure-selectivity relationships of biogenic amine GPCR antagonists using similarity searching and dynamic compound mapping. Mol. Divers. 12, 25–40.
Priss, U. (2006) Formal concept analysis in information science. Annu. Rev. Inform. Sci. Technol. 40, 521–543.
Lounkine, E., Auer, J., and Bajorath, J. (2008) Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds. J. Med. Chem. 51, 5342–5348.
Lounkine, E., Stumpfe, D., and Bajorath, J. (2009) Molecular Formal Concept Analysis for compound selectivity profiling in biologically annotated databases. J. Chem. Inf. Model. 49, 1359–1368.
Duvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., and Frankel, S. R. (2007) Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109, 31–39.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Humana Press
About this protocol
Cite this protocol
Stumpfe, D., Lounkine, E., Bajorath, J. (2011). Molecular Test Systems for Computational Selectivity Studies and Systematic Analysis of Compound Selectivity Profiles. In: Bajorath, J. (eds) Chemoinformatics and Computational Chemical Biology. Methods in Molecular Biology, vol 672. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-839-3_20
Download citation
DOI: https://doi.org/10.1007/978-1-60761-839-3_20
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-838-6
Online ISBN: 978-1-60761-839-3
eBook Packages: Springer Protocols